Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04459273
What this trial is testing

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

Who this might be right for
Bladder CarcinomaCervical CarcinomaCholangiocarcinoma+13 more
Jonsson Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)UnknownNCT03654703
What this trial is testing

Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML

Who this might be right for
Hematopoietic System--Cancer
Capital Research Institute of Pediatrics 100
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Early research (Phase 1)Ended earlyNCT03465540
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies

Who this might be right for
Multiple MyelomaAcute Myeloid LeukemiaNon-Hodgkins Lymphoma+4 more
Amgen 24
Not applicableUnknownNCT05566535
What this trial is testing

Changes in QoL and Symptoms in Patients With Polycythemia Vera Receiving Ruxo in a Routine Clinical Practice

Who this might be right for
Polycythemia Vera
Multinational Center for Quality of Life Research, Russia 32
Early research (Phase 1)Not Yet RecruitingNCT07616089
What this trial is testing

Phase I Study of FXS0683 in the Treatment of Blood Tumors

Who this might be right for
B-Cell LymphomaAcute Myeloid LeukemiaMyelodysplastic Syndromes+1 more
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 228
Not applicableEnrolling By InvitationNCT06925685
What this trial is testing

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product

Who this might be right for
Hematologic MalignanciesSolid Tumors
Allogene Therapeutics 50
Not applicableLooking for participantsNCT07445438
What this trial is testing

Feasibility of a Multi-omics Platform for Hematological Malignancies

Who this might be right for
Myeloma MultipleChronic LeukemiaAcute Leukemia+3 more
Azienda Ospedaliero-Universitaria di Parma 1,040
Not applicableStudy completedNCT07839858
What this trial is testing

Real-world Use and Effectiveness of Cytoreductive Strategies for the Treatment of Second-line Polycythemia Vera in France

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals 237
Testing effectiveness (Phase 2)Active Not RecruitingNCT05485948
What this trial is testing

Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU

Who this might be right for
Polycythemia Vera
PharmaEssentia 49
Early research (Phase 1)WithdrawnNCT00003435
What this trial is testing

Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer

Who this might be right for
LeukemiaLymphoma
Duke University
Testing effectiveness (Phase 2)WithdrawnNCT04282174
What this trial is testing

CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies

Who this might be right for
Hematologic DiseasesHematologic MalignancyAcute Lymphoblastic Leukemia+3 more
Baptist Health South Florida
Large-scale testing (Phase 3)UnknownNCT01217723
What this trial is testing

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Who this might be right for
Hematologic Malignancies
McMaster University 198
Testing effectiveness (Phase 2)Study completedNCT04112810
What this trial is testing

Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease

Who this might be right for
Hematologic Malignancies
Medical College of Wisconsin 51
Not applicableStudy completedNCT02188290
What this trial is testing

Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 178
Not applicableStudy completedNCT02893410
What this trial is testing

Drug Observance and Side Effects of Cytoreductive Drugs in PV and ET Patients

Who this might be right for
Polycythemia VeraEssential Thrombocythemia
University Hospital, Brest 286
Early research (Phase 1)Ended earlyNCT03320642
What this trial is testing

GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

Who this might be right for
Hematologic Malignancies
Incyte Corporation 84
Testing effectiveness (Phase 2)WithdrawnNCT03986086
What this trial is testing

MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematologic Malignancy
Nelson Chao
Large-scale testing (Phase 3)Study completedNCT04620369
What this trial is testing

Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving Chemotherapy

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmNasal Vestibulitis
Mayo Clinic 106
Not applicableAvailableNCT04745637
What this trial is testing

Managed Access Programs for INC424, Ruxolitinib

Who this might be right for
Primary Myelofibrosis (PMF)Post Polycythemia Myelofibrosis (PPV MF)Thrombocythemia Myelofibrosis (PET-MF)+4 more
Novartis Pharmaceuticals
Next Page